1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
MRI-only radiotherapy from an economic perspective : Can new techniques in prostate cancer treatment be cost saving?
Persson, Emilia LU ; Svanberg, Niklas ; Scherman, Jonas ; Jamtheim Gustafsson, Christian LU ; Fridhammar, Adam ; Hjalte, Frida ; Bäck, Sven LU ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
and Olsson, Lars E
LU
(2023)
In Clinical and Translational Radiation Oncology
38.
p.183-187
- Contribution to journal › Article
- 2022
-
Mark
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting
- Contribution to journal › Article
-
Mark
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer
Skarping, Ida LU
; Nilsson, Kristoffer
; Dihge, Looket
LU
; Fridhammar, Adam
; Ohlsson, Mattias
LU
; Huss, Linnea
LU
; Bendahl, Pär Ola
LU
; Steen Carlsson, Katarina
LU
and Rydén, Lisa
LU
(2022)
In Breast Cancer Research and Treatment
194(3).
p.577-586
- Contribution to journal › Article
- 2021
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
Fridhammar, Adam ; Axelsson, Ulrika LU
; Persson, Ulf
; Bjartell, Anders
LU
and Borrebaeck, Carl A.K.
LU
(2021)
In PharmacoEconomics - Open
5(1).
p.77-88
- Contribution to journal › Article
- 2018
-
Mark
Intraductal papillary mucinous neoplasms of the pancreas – a cost-effectiveness analysis of management strategies for the branch-duct subtype
Aronsson, Linus LU ; Ansari, Daniel LU ; Andersson, Bodil LU
; Persson, Ulf
LU
; Fridhammar, Adam
and Andersson, Roland
LU
(2018)
In HPB
20(12).
p.1206-1214
- Contribution to journal › Article